Literature DB >> 22365299

Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.

Ricardo Garcia-Monaco1, Ana Giachetti, Oscar Peralta, Noelia Napoli, Pablo Lobos, Laura Gioseffi, Gonzalo Mariani.   

Abstract

Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor and has a high mortality in newborns when associated with Kasabach-Merritt syndrome (KMS). In two newborns with KHE and severe KMS refractory to medical treatment, emergency embolization led to clinical improvement in the acute neonatal setting by reducing tumor volume, increasing the platelet count, and improving other clotting parameters. Systemic vincristine treatment was added for further tumor control. Both patients remained symptom-free at long-term follow-up. Copyright Â
© 2012 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365299     DOI: 10.1016/j.jvir.2011.12.007

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  11 in total

1.  Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma.

Authors:  Li Kai; Zuopeng Wang; Wei Yao; Kuiran Dong; Xianmin Xiao
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-25       Impact factor: 4.553

2.  Case Report: Congenital Intracranial Kaposiform Hemangioendothelioma Treated With Surgical Resection.

Authors:  Yingjie Cai; Jiayi Li; Wei Yang; Nan Zhang; Hailang Sun; Weiping Zhang; Ming Ge
Journal:  Front Surg       Date:  2022-04-01

3.  Pulmonary manifestation of a condition resembling Kasabach-Merritt syndrome in a woman with abdominal angiomatosis associated with consumptive coagulopathy--surgical management: a case report.

Authors:  Danjouma Housmanou Cheufou; Thomas Hager; Stefan Welter; Dirk Theegarten; Georgios Stamatis
Journal:  J Med Case Rep       Date:  2015-05-09

4.  Clinical analysis of Kasabach-Merritt syndrome in 17 neonates.

Authors:  Ping Wang; Wei Zhou; Li Tao; Ning Zhao; Xiao-Wen Chen
Journal:  BMC Pediatr       Date:  2014-06-11       Impact factor: 2.125

5.  Excellent outcome of medical treatment for Kasabach-Merritt syndrome: a single-center experience.

Authors:  Jin Ah Kim; Young Bae Choi; Eun Sang Yi; Ji Won Lee; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Blood Res       Date:  2016-12-23

Review 6.  Kasabach-Merritt Phenomenon: Classic Presentation and Management Options.

Authors:  Priya Mahajan; Judith Margolin; Ionela Iacobas
Journal:  Clin Med Insights Blood Disord       Date:  2017-03-16

7.  Effective surgical treatment of life-threatening huge vascular anomalies associated with thrombocytopenia and coagulopathy in infants unresponsive to drug therapy.

Authors:  Yaohao Wu; Ronglin Qiu; Lexiang Zeng; Liyang Liang; Jie Zhang; Jiajia Zhou; Wenli Jiang; Jianhang Su; Xiaogeng Deng
Journal:  BMC Pediatr       Date:  2020-04-27       Impact factor: 2.125

8.  Analysis of angiographic characteristics of kaposiform hemangioendothelioma and investigation of the value of transcatheter arterial embolization therapy.

Authors:  Xiaoyun Tan; Zhenyin Liu; Shaoyi Zhou; Kunshan Chen; Ming Zhang; Jiejun Xia; Yiqun Guo; Zijun Zhou
Journal:  Transl Pediatr       Date:  2021-12

9.  Chemotherapy and surgical approach with repeated endovascular embolizations: safe interdisciplinary treatment for kasabach-merritt syndrome in a small baby.

Authors:  Ghassan Nakib; Valeria Calcaterra; Pietro Quaretti; Lorenzo Paolo Moramarco; Giovanni Bonalumi; Marco Brunero; Gloria Pelizzo
Journal:  Case Rep Oncol       Date:  2014-01-10

10.  Successful Management of Kaposiform Hemangioendothelioma with Long-Term Sirolimus Treatment: a Case Report and Review of the Literature.

Authors:  Matteo Chinello; Daniela Di Carlo; Francesca Olivieri; Rita Balter; Massimiliano De Bortoli; Virginia Vitale; Ada Zaccaron; Elisa Bonetti; Alice Parisi; Simone Cesaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.